Altium Capital Management LP - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
Altium Capital Management LP ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,749,060
+33.0%
34,000
+54.5%
3.00%
+36.5%
Q4 2022$4,323,000
+13.0%
22,000
+29.4%
2.20%
+56.7%
Q3 2022$3,824,000
+132.5%
17,000
+30.8%
1.40%
+113.1%
Q2 2022$1,645,000
-38.2%
13,000
-38.1%
0.66%
-26.2%
Q1 2022$2,663,00021,0000.89%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders